Searched for
LAMIVUDINE TABLETS
Lupin gets USFDA nod for generic HIV drugLupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at Lupin's Nagpur ...- Anti-diabetes drugs and patented antivirals to get cheaper, NLEM notifiedFor the first time, patented drugs like anti-TB bedaquiline and delamanid, anti-HIV Dolutegravir and anti-hepatitis C daclatasvir are also ...
- Adequate stock of antiretroviral drugs for 95% 'People Living with HIV' in India: SourcesThere is no reported stock out for any antiretroviral (ARV) drugs at the state level and fresh supply orders for procurement of the next lo...
- Lupin gets USFDA nod for HIV drug under PEPFARLupin got a green signal from the US health regulator to sell HIV drug in the American market. The product that has received a nod under US...
- Trending stocks: Laurus Labs shares climb 4%A total of 70,447 shares changed hands on the counter till 02:31PM (IST).
- Zydus Cadila gets USFDA nod to market generic HIV treatment tabletsThe approval from the USFDA is for Abacavir and Lamivudine tablets USP in the strength of 600 mg/300 mg, Zydus Cadila said.
- Aurobindo Pharma gets nod from South African health authority for HIV drugThe approval further strengthens the company's HIV product basket in South Africa, which has the potential to improve the lives of millions...
- Aurobindo Pharma gets USFDA nod for anti-HIV drugAurobindo Pharma has received tentative approval from the USFDA for dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets, use...
- Aurobindo Pharma gets USFDA nod for HIV drug"The company has received final approval from the USFDA to manufacture abacavir sulfate and lamivudine tablets, 600 mg/ 300 mg."
- Lupin launches generic HIV drug in US marketThe company had earlier received approval from the United States Food and Drug Administration for Abacavir and Lamivudine tablets 600 mg/30...
- Government exempts AIDS drugs from customs dutyThe exemption will benefit Anti-Retroviral Drugs (ARV Drugs) -- Adult First Line, Adult Second Line and Paediatric Drugs.
- US FDA approves sale of Strides Arcolab's HIV treatment drugStrides Arcolab said US health regulator has approved its drug used for treating HIV infection in adult and children for sale in US market.
- Lupin rallies over 1% on acquisition plans, USFDA HIV drug approvalLupin Ltd rallied as much as 1.5 per cent in trade on Monday on reports that that the drug major is eyeing acquisitions in various global m...
- Lupin gets USFDA approval for HIV drugThe Mumbai-based firm has received final approval from the US Food and Drug Administration for its Lamivudine tablets in strengths of 150 m...
- Lupin launches HIV drug in the US with marketing exclusivityLupin launched the generic version of ViiV Healthcare's Trizivir tablets in the US market with 180-days of marketing exclusivity.
- Lupin gets USFDA nod to market HIV drug in the US marketThe company's product is indicated in combination with other antiretrovirals or alone for the treatment of HIV-1 infection, it added.
- Aurobindo Pharma gets USFDA nod for HIV infection tabletsThis NDA was reviewed under the President's Emergency Plan for AIDS Relief (PEPFAR), Aurobindo Pharma said.
- Lupin, Aurobindo get USFDA nod for HIV drugDrug firms Lupin Ltd and Aurobindo Pharma today said they have received approval to sell generic Combivir tablets, used in treating HIV inf...
- Strides Arcolab receives US FDA nod for HIV drugDrug firm Strides Arcolab today said it has received tentative approval from US health regulator for fixed dose combination of Lamivudine a...
- Aurobindo gets tentative USFDA nod for HIV-1 drugAurobindo Pharma on Monday said it has received a tentative New Drug Approval from USFDA for its fixed dose combination product used for tr...
Load More
